zonisamide has been researched along with SUNCT Syndrome in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
SUNCT Syndrome: A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide was selected for continued treatment, as a Na-channel blocker like carbamazepine but with lower risk of producing skin rashes as caused by carbamazepine." | 5.37 | A case of SUNCT syndrome responsive to zonisamide. ( Ikawa, M; Imai, N; Manaka, S, 2011) |
| "Zonisamide was selected for continued treatment, as a Na-channel blocker like carbamazepine but with lower risk of producing skin rashes as caused by carbamazepine." | 1.37 | A case of SUNCT syndrome responsive to zonisamide. ( Ikawa, M; Imai, N; Manaka, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikawa, M | 1 |
| Imai, N | 1 |
| Manaka, S | 1 |
1 other study available for zonisamide and SUNCT Syndrome
| Article | Year |
|---|---|
A case of SUNCT syndrome responsive to zonisamide.
Topics: Adult; Humans; Isoxazoles; Male; SUNCT Syndrome; Zonisamide | 2011 |